1. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms
- Author
-
Margaret A Park, Thinzar Zaw, Sean J Yoder, Maria Gomez, Maria Genilo-Delgado, Toni Basinski, Esther Katende, Aamir Dam, Shaffer R S Mok, Alvaro Monteiro, Amir Mohammadi, Daniel K Jeong, Kun Jiang, Barbara A Centeno, Pamela Hodul, Mokenge Malafa, Jason Fleming, Dung-Tsa Chen, Qianxing Mo, Jamie K Teer, and Jennifer B Permuth
- Subjects
Genetics ,QH426-470 - Abstract
AbstractIntraductal papillary mucinous neoplasms (IPMNs) are precursor lesions to pancreatic ductal adenocarcinoma that are challenging to manage due to limited imaging, cytologic, and molecular markers that accurately classify lesions, grade of dysplasia, or focus of invasion preoperatively. The objective of this pilot study was to determine the frequency and type of DNA mutations in a cohort of surgically resected, pathologically confirmed IPMN, and to determine if concordant mutations are detectable in paired pretreatment plasma samples. Formalin-fixed paraffin-embedded (FFPE) tissue from 46 surgically resected IPMNs (31 low-grade, 15 high-grade) and paired plasma from a subset of 15 IPMN cases (10 low-grade, 5 high-grade) were subjected to targeted mutation analysis using a QIAseq Targeted DNA Custom Panel. Common driver mutations were detected in FFPE from 44 of 46 (95.6%) IPMN cases spanning all grades; the most common DNA mutations included: KRASRNF43GNASRNF43P
- Published
- 2022
- Full Text
- View/download PDF